TY - JOUR
T1 - Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
AU - Michaels, Thomas C.T.
AU - Šarić, Andela
AU - Curk, Samo
AU - Bernfur, Katja
AU - Arosio, Paolo
AU - Meisl, Georg
AU - Dear, Alexander J.
AU - Cohen, Samuel I.A.
AU - Dobson, Christopher M.
AU - Vendruscolo, Michele
AU - Linse, Sara
AU - Knowles, Tuomas P.J.
PY - 2020
Y1 - 2020
N2 - Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as potent cytotoxins linked to Alzheimer’s disease, but the fundamental molecular pathways that control their dynamics have yet to be elucidated. By developing a general approach that combines theory, experiment and simulation, we reveal, in molecular detail, the mechanisms of Aβ42 oligomer dynamics during amyloid fibril formation. Even though all mature amyloid fibrils must originate as oligomers, we found that most Aβ42 oligomers dissociate into their monomeric precursors without forming new fibrils. Only a minority of oligomers converts into fibrillar structures. Moreover, the heterogeneous ensemble of oligomeric species interconverts on timescales comparable to those of aggregation. Our results identify fundamentally new steps that could be targeted by therapeutic interventions designed to combat protein misfolding diseases. [Figure not available: see fulltext.].
AB - Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as potent cytotoxins linked to Alzheimer’s disease, but the fundamental molecular pathways that control their dynamics have yet to be elucidated. By developing a general approach that combines theory, experiment and simulation, we reveal, in molecular detail, the mechanisms of Aβ42 oligomer dynamics during amyloid fibril formation. Even though all mature amyloid fibrils must originate as oligomers, we found that most Aβ42 oligomers dissociate into their monomeric precursors without forming new fibrils. Only a minority of oligomers converts into fibrillar structures. Moreover, the heterogeneous ensemble of oligomeric species interconverts on timescales comparable to those of aggregation. Our results identify fundamentally new steps that could be targeted by therapeutic interventions designed to combat protein misfolding diseases. [Figure not available: see fulltext.].
U2 - 10.1038/s41557-020-0452-1
DO - 10.1038/s41557-020-0452-1
M3 - Article
C2 - 32284577
AN - SCOPUS:85084027236
SN - 1755-4330
VL - 12
SP - 445
EP - 451
JO - Nature Chemistry
JF - Nature Chemistry
IS - 5
ER -